Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-016996

Options or other derivatives

  • Executive Vice President acquired 347,490 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shah Nikita Executive Vice President 2021-03-01 Grant or award · Restricted Stock Units +115,830 115,830 D
Shah Nikita Executive Vice President 2021-03-01 Grant or award · Performance-Based Restricted Stock Units +231,660 231,660 D
Loading xslF345X03/doc4.xml…